Clinical Trial

Emergency Medicine Pulmonary Embolism Testing Multicentre Study

Study acronym: EMPET
Recruiting
View on ClinicalTrials.gov →
Summary
It is important to diagnose pulmonary embolism in a timely manner to prevent death and long-term disability. More than half a million people (4-5% of emergency department patients) are tested for pulmonary embolism, although the positive rate is low. Imaging for PE testing exposes patients to radiation, is expensive, adds time to the emergency visit, and can lead to a false positive diagnoses. Existing protocols aimed at reducing unnecessary pulmonary embolism imaging are complex and seldom used by emergency physicians. Too many patients undergo unnecessary pulmonary embolism imaging. A new tool (called Adjust-Unlikely) could safely reduce pulmonary embolism imaging in Canada. A research group composed of researchers, emergency physicians, and patients developed the Adjust-Unlikely clinical decision rule: a rule which has been customized for emergency physicians and emergency patients. Adjust-Unlikely is highly sensitive at the bedside, meaning there are very few false negative results. The study aim is to prospectively validate Adjust-Unlikely pulmonary embolism testing in emergency patients with suspected pulmonary embolism.
Protocol Amendment History 1 change
notable Trial sites expanded: 1 -> 4 locations 2026-04-21
Trial Details
NCT Number NCT06320236
Lead Sponsor Dr. Kerstin de Wit
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions Pulmonary Embolism, D-dimer, Diagnosis
Enrollment 4,000 participants
Start Date 2024-01-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-20